- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02918045
Dental Extractions in Patients Under Dual Antiplatelet Therapy (DUALex)
September 6, 2019 updated by: Bruno Guardieiro, University of Sao Paulo General Hospital
Dental Extractions in Patients Under Dual Antiplatelet Therapy: Comparison of Two Local Hemostatic Techniques
The purpose of this study is to compare two hemostatic agents in patients under dual antiplatelet therapy using the intraoral bleeding time after dental extractions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Postoperative hemostasis is a fundamental patient management issue in the oral and maxillofacial surgery setting.
The risk of excessive bleeding prompts physicians to stop multiple antiplatelet agents before minor surgery, which puts coronary stenting patients at risk for adverse thrombotic events.
Adequate hemostasis must be achieved in order to make oral surgeries possible for these patients without discontinuation of the antiplatelet regimen.
The HemCon Dental Dressing (HemCon Medical Technologies, Inc, Beaverton, OR) is a novel chitosan-based hemostatic agent which may greatly improve upon the efficacy of wound healing and hemostasis both in extent and time for minor oral surgeries.
Dental extractions will be performed in patients under dual antiplatelet therapy without altering their medication regimen.
All patients will require to have two or more surgical sites so they will have internal surgical control sites.
Cutaneous bleeding time and platelet aggregation tests will be obtained prior to extractions.
The primary hemostasis will be evaluated by measuring the intraoral bleeding time after each extraction and further bleeding and healing outcomes will be ascertain by phone questionaires and clinical evaluations.
The aim of this study is to evaluate the effectiveness of HemCon Dental Dressing in controlling post extraction bleeding and to ascertain its role in healing of extraction wounds compared to a standard haemostasis method.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil
- Instituto do Coração (InCor HCFMUSP)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients requiring two or more dental extraction procedures.
- Patients must be under dual antiplatelet therapy of any kind.
- Patients must be 18 years of age or older.
- Patients must be available for a minimum of one post operative evaluation to be scheduled at the time of the procedure approximately 7 days post surgery.
- Extraction sites do not require primary closure of suturing.
- Willingness and ability to provide informed consent
Exclusion Criteria:
- Patients who are currently undertaking other anticoagulant medications (e.g., aspirin, coumadin, heparin) or have discontinued their anticoagulant medications.
- History of heart attack in less than 1 week.
- Patients with seafood allergy.
- Unable of unwilling to provide informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Hemcon Dental Dressing
The HemCon® Bandage is an FDA-cleared chitosan-based flat bandage that controls severe arterial bleeding from traumatic injuries.
In comparison to traditional bandages, the HemCon® Bandage provides superior control of bleeding, wound site adhesiveness, multiple injury site usage, biocompatibility and provides a barrier to infective agents.
|
The Hemcon Dental Dressing is an oral wound dressing made of chitosan.
|
ACTIVE_COMPARATOR: Oxidized Cellulose Gauze
A common hemostatic measure after dental extractions involves the placement of an absorbable oxidized cellulose gauze Surgicel (Ethicon, Inc, San Angelo, TX) into the extraction socket.
This treatment was chosen as the study control to compare the HemCon Dental Dressing to the standard local hemostatic care for oral surgery subjects.
|
A common hemostatic measure after dental extractions placed into the extraction socket.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary bleeding
Time Frame: Intraoperative
|
Primary bleeding will be evaluated by recording the intra-oral bleeding time.
The extraction site will be observed for 2 min without gauze in place.
At the end of 2 min, gauze is placed over the extraction site to remove blood extending beyond the tooth socket.
After blotting the extraction site, any bleeding that extends beyond the crest of the socket will be recorded as a positive test result (i.e., onto surrounding gingival tissues) during an observation period of 1 min.
This same procedure was performed at 5, 8, 11, 14, and 20 min after the extraction.
Intra-oral bleeding time is defined as the length of time for bleeding to cease to extend beyond the tooth socket.
|
Intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Point-of-care platelet function test
Time Frame: Day before dental extraction
|
Blood platelet function plays a pivotal role in hemostasis during surgery and following traumatic injuries.
The ability to assess platelet function before the intervention is desirable in patients undergoing dental extraction procedures.
A point-of-care platelet function test (Multiplate - Roche Diagnostics, Mannheim, Germany) will be performed the morning before dental extraction to assess platelet function inhibition due to dual antiplatelet therapy.
|
Day before dental extraction
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary bleeding (T1)
Time Frame: 10-15 hours after dental extraction
|
Secondary bleeding (T1) will be evaluated by telephone with standardized questionnaire including the following: whether bleeding occurred after the individual left the dental clinic (y/n); whether gauze was needed to be placed due to bleeding (y/n); and whether an emergency service or dental clinic was visited due to bleeding (y/n).
|
10-15 hours after dental extraction
|
Secondary bleeding (T2)
Time Frame: 45-50 hours after dental extraction
|
Secondary bleeding (T2) will be evaluated by telephone with standardized questionnaire including the following: whether bleeding occurred after the individual left the dental clinic (y/n); whether gauze was needed to be placed due to bleeding (y/n); and whether an emergency service or dental clinic was visited due to bleeding (y/n).
|
45-50 hours after dental extraction
|
Intra patient healing comparison
Time Frame: 1 week post surgery
|
Healing will be compared between the study and control sites and assessed on a scale of 1-3 with 1 representing the healing of the study site being significantly worse than the control; 2 representing the healing of the study site being the same as the control, and 3 meaning the healing of the study site was significantly better than the control.
|
1 week post surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Itamara LI Neves, PhD, University of Sao Paulo
- Study Director: José C Nicolau, PhD, University of Sao Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 11, 2017
Primary Completion (ACTUAL)
July 16, 2019
Study Completion (ACTUAL)
July 23, 2019
Study Registration Dates
First Submitted
September 21, 2016
First Submitted That Met QC Criteria
September 26, 2016
First Posted (ESTIMATE)
September 28, 2016
Study Record Updates
Last Update Posted (ACTUAL)
September 10, 2019
Last Update Submitted That Met QC Criteria
September 6, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DUALex
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Coagulation Disorders
-
Groupe Hospitalier Paris Saint JosephCompletedCoagulation DisorderFrance
-
Cairo UniversityRecruitingCoagulation DisorderEgypt
-
Stony Brook UniversityCompletedCoagulation DisorderUnited States
-
HemoSonics LLCCompleted
-
TakedaTakeda Development Center Americas, Inc.RecruitingCoagulation DisorderUnited States, Spain, Belgium, France, Netherlands
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
VarmX B.V.Completed
-
HemoSonics LLCIRCCS Policlinico S. DonatoCompletedCoagulation DisorderItaly
-
Masaryk Hospital Krajská zdravotní a.s.CompletedCoagulation Disorder | Multiple Trauma | Coagulation Defect; Acquired | Coagulation Factor DeficiencyCzechia
Clinical Trials on HemCon Dental Dressing
-
HemCon Medical Technologies, IncWithdrawnTooth ExtractionsUnited States
-
HemCon Medical Technologies, IncCompletedTooth ExtractionsUnited States
-
HemCon Medical Technologies, IncCompletedEpistaxisUnited States
-
Meir Medical CenterCompletedCoronary AngiographyIsrael
-
HemCon Medical Technologies, IncTerminatedWound DebridementUnited States
-
United States Army Institute of Surgical ResearchCompleted
-
Maria Jesus PerezInstituto de Salud Carlos IIIUnknownCardiac Surgery
-
University of British ColumbiaCompletedCentral Line ComplicationCanada
-
Augusta UniversityCompleted
-
Corporacion Parc TauliCompletedDiabetic Foot Ulcer | Diabetic Foot Ulcer NeuropathicPakistan